| Sign In to gain access to subscriptions and/or personal tools. |
Beta Blockers and Lactation: An UpdateSearle Pharmaceuticals in Skokie, Illinois; University of Illinois at Chicago
Global Healthcare Resources at Searle; 5200 Old Orchard Road, Skokie, IL 60077 USA susan.e.malecha{at}monsanto.com
Global Healthcare Resources at Searle Beta-adrenergic antagonists are one of the most commonly used class of agents in the treatment of hypertension. They have also demonstrated utility in the treatment of angina pectoris and certain arrhythmias and for the reduction in mortality following a myocardial infarction. The use of this class of agents creates the potential for beta-blocker exposure among lactating women. This review focuses on the most up-to-date data regarding the more common agentsmetoprolol, atenolol, propranolol, carvedilol, nadolol, sotalol, and betaxololand their safety in lactating women.
Key Words: breastfeeding lactation beta blocker hypertension
Journal of Human Lactation, Vol. 16, No. 3,
240-245 (2000) |
|||